Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics Stock Forecast

Stock Price Forecast

The 17 analysts that cover Atrium Therapeutics stock have a consensus rating of "Buy" and an average price target of $66.12, which forecasts a 417.78% increase in the stock price over the next year. The lowest target is $25 and the highest is $96.

Price Target: $66.12 (+417.78%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$25	$66.12	$68	$96
Change	+95.77%	+417.78%	+432.50%	+651.76%

* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for Atrium Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	4
Buy	7	7	7	7	6	5
Hold	9	9	9	9	9	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	20	20	20	19	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yanan Zhu Wells Fargo	Wells Fargo	Buy Initiates $25	Buy	Initiates	$25	+95.77%	Mar 11, 2026
Keay Nakae Chardan Capital	Chardan Capital	Hold Maintains $72	Hold	Maintains	$72	+463.82%	Nov 11, 2025
Ritu Baral TD Cowen	TD Cowen	Strong Buy → Hold Downgrades $78 → $74	Strong Buy → Hold	Downgrades	$78 → $74	+479.48%	Oct 29, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy → Hold Downgrades $75 → $72	Strong Buy → Hold	Downgrades	$75 → $72	+463.82%	Oct 28, 2025
Luca Issi RBC Capital	RBC Capital	Buy → Hold Downgrades $61 → $72	Buy → Hold	Downgrades	$61 → $72	+463.82%	Oct 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

8.08M

Decreased by -56.60%

from 18.62M

Revenue Next Year

8.08M

from 8.08M

EPS This Year

-4.18

from -3.19

EPS Next Year

-4.67

from -4.18

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	9.76M	10.90M	18.62M	8.08M	8.08M
Revenue Growth	-	11.60%	70.85%	-56.60%	-
EPS	-	-	-3.19	-4.18	-4.67
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	8.4M	8.4M
Avg	8.1M	8.1M
Low	7.8M	7.8M

Revenue Growth

Revenue Growth	2026	2027
High	-54.9%	4.0%
Avg	-56.6%	-
Low	-57.9%	-3.0%

EPS Forecast

EPS	2026	2027
High	-4.35	-4.85
Avg	-4.18	-4.67
Low	-4.06	-4.53

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.